MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

Meeting: 2019 International Congress

Abstract Number: 1622

Keywords: Non-motor Scales, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS).

Background: The NMSS was the first comprehensive assessment for non-motor symptoms (NMS) in Parkinson disease (PD). The MDS-NMS has been recently developed based on the original NMSS, literature review, and expert consensus, to expand and refine the assessment of NMS.

Method: Multi-center, cross-sectional study to validate MDS-NMS in a sample of 402 PD patients recruited from movement disorders clinics in UK and US. Data on socio-demographic characteristics and PD treatment were obtained. The MDS-NMS was administered together along with the NMSS. Frequency of NMS (i.e., scores >0) by items and domains, mean and standard deviation (SD), comparison of scores in the sample grouped by age, sex, PD duration, Hoehn and Yahr stage (HY), and levodopa-equivalent daily dose (LEDD) were calculated.

Results: The sample (62.2% men) had mean age of 67.42 years old (SD: 9.96), PD duration of 8.2 years (SD: 5.93), and mainly HY stage 2 (54.5%). Mean total scores were: MDS-NMS, 79.33 (SD: 65.87, range: 0-334) and NMSS, 41.39 (SD: 35.2, range: 0-197). Most prevalent MDS-NMS domains were K. Sleep & Wakefulness (86.5%) and F. Cognition and M. Other (both, 80.1%). For NMSS, most prevalent domains were 2. Sleep/fatigue (79.9%) and 7. Urinary (73.3%). MDS-NMS items L1. Muscle/joint/back pain (67.5%) and F1. Difficulty remembering things (59.2%), and NMSS items 28. Change in ability to taste/smell (54.7%) and 17. Forgetting things (52.5%) were the most prevalent individual symptoms. Neither MDS-NMS nor NMSS total scores showed significant differences by sex or age groups, but both increased with increasing PD duration and LEDD (p<0.001). Most MDS-NMS and NMSS domains scores also increased with increasing HY stages (p<0.01).

Conclusion: Due to the inherent similarities, there are overlapping attributes of the MDS-NMS and NMSS (e.g., score distribution by groups), but differences are also evident (e.g., in frequency of individual NMS) because of their structural dissimilarities.

To cite this abstract in AMA style:

A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin. Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS) [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/comparison-between-the-movement-disorders-society-non-motor-rating-scale-mds-nms-and-the-non-motor-symptoms-scale-nmss/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-between-the-movement-disorders-society-non-motor-rating-scale-mds-nms-and-the-non-motor-symptoms-scale-nmss/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley